Pediatric Gastroenterology and Hepatology in Italy before and after the COVID-19: Lessons learned and management changes by SIGENP

Italian Journal of Pediatrics

Review

Paolo Lionetti¹  Marco Deganello Saccomani²  Silvia Salvatore³  Caterina Strisciuglio⁴  Renato Tambucci⁵  Valeria Dipasquale⁶  Claudio Romano⁶  Salvatore Oliva⁷  Angelo Di Giorgio⁸ 

[1] Department NEUROFARBA, University of Florence, Gastroenterology and Nutrition Unit, Meyer Children’s Hospital, Florence, Italy;Department of Pediatrics, Woman’s & Children’s University Hospital of Verona, 37126, Verona, Italy;Department of Pediatrics, “F. Del Ponte” Hospital, University of Insubria, Varese, Italy;Department of Woman, Child and General and Specialistic Surgery, University of Campania “Vanvitelli”, Naples, Italy;Digestive Endoscopy Unit, Department of Gastroenterology, Hepatology and Nutrition, Bambino Gesù Children’s Hospital, Rome, Italy;Pediatric Gastroenterology and Cystic Fibrosis Unit, Department of Human Pathology in Adulthood and Childhood “G. Barresi”, University of Messina, Messina, Italy;Pediatric Gastroenterology and Liver Unit, Maternal and Child Health Department, Sapienza University of Rome, Rome, Italy;Pediatric Hepatology, Gastroenterology and Transplantation, Hospital Papa Giovanni XXIII, Bergamo, Italy;

关键词: Anti-TNF-α;    COVID-19;    Digestive endoscopy;    Hepatitis;    Inflammatory bowel disease;    Liver disease;    Pediatrics;    SARS-CoV-2;    SIGENP;    Telemedicine;   

DOI  :  10.1186/s13052-023-01418-7

 received in 2022-12-08, accepted in 2023-01-21,  发布年份 2023

来源: Springer

【 摘 要 】

Around the world, the 2019 Coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has raised serious public health problems and major medical challenges. The Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP) published several papers on the impact of COVID-19 on the current management, diagnosis, and treatment of acute and chronic gastrointestinal, hepatic, immune-mediated, and functional disorders. The present article summarizes the most relevant SIGENP reports and consensus during and after the peak of the COVID-19 outbreak, including the diagnosis and treatment of inflammatory bowel disease (IBD), indications and timing of digestive endoscopy, and insights into the novel hepatitis.

【 授权许可】

CC BY   
© The Author(s) 2023